Lack of funding is threatening development of a nasal spray vaccine shown to provide long-term protection for non-human primates against the Ebola virus, the lead researcher told this publication in an exclusive interview.
The World Health Organisation says a meeting between drugmakers and high-level government representatives last week has yielded plans to fast-track scale-up of Ebola vaccines in the face of incomplete trials and leaked production problems.
As the death toll from the world’s most expansive Ebola outbreak nears 1,000, multiple companies are stepping up efforts to bring antibodies and other vaccines to human trials, though none seem likely to be ready until 2015 at the earliest.
The worst Ebola virus outbreak in history continues to spread in West Africa as biopharma companies are hampered by funding issues in trying to bring treatments and vaccines to human trials, a scientist says.
PPD has expanded its central lab testing services at its Brussels and Singapore labs and will offer additional services in microbiology, peripheral blood mononuclear cell and molecular pathology services.
A new, freely available database has been launched that provides
comprehensive information about the 600 known bacteria living in
the human mouth. Many of these bacteria also cause infections
in the lungs, blood and skin, so the...
Danish biotechnology firm Novozymes has acquired Delta
Biotechnology from sanofi-aventis, looking to strengthen its
bioprocessing expertise in enzymes and microorganisms with Delta's
ability to manufacture recombinant proteins...
After receiving a grant of $3.9m (€3m) from the US government,
British biotechnology firm Avecia has put together a consortium of
four companies to develop a version of its anthrax vaccine with
increased stability so it works without...
The European Medicines Agency (EMEA) has given Sanofi Pasteur the
green light to market a childhood vaccine containing Delta's
Recombumin, a recombinant human albumin which offers the world's
first and only animal-free alternative...
UK's Biotrace has signed a deal giving US company Pall Corporation
exclusive global marketing and distribution rights to its range of
microbiological air monitoring products for the pharma industry in
order to broaden the geographic...
Filtration specialists, Pall, and Biotrace have signed an agreement
to market microbiological air monitoring technology to the
pharmaceutical industry. The deal focuses on microbiological
monitoring of manufacturing processes, which...
Greenbridge Environmental Control of the UK has introdueced a new
cleaner and disinfectant agent, suitable for commercial scale
applications, that is claimed to be the first non-toxic product of
Celsis International has signed a collaboration with BioVentures to
develop a microarray-based microbiological testing system to detect
contamination in pharmaceutical, biotechnology and other process
A new approach to prevent infection of West Nile and dengue fever
may be on the horizon after a US team identified interactions
involving the alfalfa mosaic virus (AMV). The virus is a close
relative of the flaviviruses that cause...
Dutch biotechnology company Crucell has announced a new project
aimed at developing a vaccine for West Nile virus, a flu-like
illness that can cause a brain infection with a mortality rate of 1
Aventis has licensed in a new system from US firm SciQuest aimed at
enhancing the management of biological sample inventories at its
process development facilities in Frankfurt, Germany and
Vitry-sur-Seine in France. If this initial...